Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $1.07 Million - $1.25 Million
-20,000 Reduced 44.44%
25,000 $1.56 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $1.55 Million - $1.69 Million
-25,000 Reduced 35.71%
45,000 $3.01 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $1.44 Million - $1.64 Million
25,000 Added 55.56%
70,000 $4.34 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $574,300 - $636,400
-10,000 Reduced 18.18%
45,000 $2.71 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $2.47 Million - $2.88 Million
45,000 Added 450.0%
55,000 $3.23 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $492,100 - $641,900
10,000 New
10,000 $642,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track J. L. Bainbridge & Co., Inc. Portfolio

Follow J. L. Bainbridge & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.